Latest / The BioHub - by Avetix
Episode 94 - Cameron Turtle - CEO of Spyre Therapeutics
On this episode we welcomed Cameron Turtle, CEO of Spyre Therapeutics during the Jefferies Healthcare conference.
Spyre are developing next-generation antibodies, engineered for prolonged activity in the body and formulated for delivery as monotherapies or combination therapies to validated inflammatory targets. Their approach has the potential to deliver uncompromising efficacy and convenience for patients in a number of autoimmune indications.
This podcast was recorded in November 2025. Comments made during this podcast contain forward-looking statements within the meaning of the Private…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.